Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Sankhala Kk"'
Publikováno v:
International Medical Case Reports Journal, Vol Volume 15, Pp 7-14 (2022)
Sol Lee,1 Kamalesh K Sankhala,2 Swaraj Bose,3 Ron P Gallemore1 1Department of Clinical Research, Retina Macula Institute, Torrance, CA, USA; 2Cedars-Sinai Medical Center, Beverly Hills, CA, USA; 3NeuroOphthalmology & Orbital Surgery, Cedars-Sinai Med
Externí odkaz:
https://doaj.org/article/9cc7ac1cb505470ca80da75759cf39e9
Publikováno v:
SM Journal of Orthopedics. 2:1-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e38d970727257f94f2140c0c568c0038
https://doi.org/10.36876/smjo.1040
https://doi.org/10.36876/smjo.1040
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kesari S; Pacific Neuroscience Institute, Santa Monica, California.; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, California., Wagle N; Pacific Neuroscience Institute, Santa Monica, California.; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, California., Carrillo JA; Pacific Neuroscience Institute, Santa Monica, California.; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, California., Sharma A; Pacific Neuroscience Institute, Santa Monica, California.; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, California., Nguyen M; Pacific Neuroscience Institute, Santa Monica, California.; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, California., Truong J; Pacific Neuroscience Institute, Santa Monica, California.; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, California., Gill JM; Pacific Neuroscience Institute, Santa Monica, California.; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, California., Nersesian R; Pacific Neuroscience Institute, Santa Monica, California.; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, California., Nomura N; Pacific Neuroscience Institute, Santa Monica, California.; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, California., Rahbarlayegh E; Pacific Neuroscience Institute, Santa Monica, California.; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, California., Barkhoudarian G; Pacific Neuroscience Institute, Santa Monica, California.; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, California., Sivakumar W; Pacific Neuroscience Institute, Santa Monica, California., Kelly DF; Pacific Neuroscience Institute, Santa Monica, California., Krauss H; Pacific Neuroscience Institute, Santa Monica, California., Bustos MA; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, California., Hoon DSB; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, California., Anker L; Providence St. Joseph Hospital Orange, Orange, California., Singh AS; UCLA Health, Santa Monica Cancer Care, Santa Monica, California., Sankhala KK; Cedars-Sinai Medical Center, Samuel Oschin Cancer Center, Los Angeles, California., Juarez TM; Pacific Neuroscience Institute, Santa Monica, California.; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jan 17; Vol. 30 (2), pp. 323-333.
Autor:
Wick A; Department of Neurology and Neurooncology Program of the National Center for Tumor Diseases, Heidelberg University Hospital & Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. antje.wick@med.uni-heidelberg.de., Bähr O; Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany., Schuler M; West German Cancer Center, Department of Medical Oncology, University Hospital Essen and German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany., Rohrberg K; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Chawla SP; Department of Medicine, Sarcoma Oncology Center, Santa Monica, California., Janku F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Center, Houston, Texas., Schiff D; Department of Neurology, University of Virginia, Charlottesville, Virginia., Heinemann V; Department of Medical Oncology and Hematology, LMU University Hospital Munich, Munich, Germany., Narita Y; Department of Neurosurgery and Neurooncology, National Cancer Center Hospital, Tokyo, Japan., Lenz HJ; Adult Oncology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California., Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Ando Y; Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan., Wick W; Department of Neurology and Neurooncology Program of the National Center for Tumor Diseases, Heidelberg University Hospital & Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Steinbach JP; Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany., Burger MC; Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany., Wenger K; Dr. Senckenberg Institute of Neurooncology, Department of Neuroradiology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany., Lassen U; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Sankhala KK; Department of Medicine, Sarcoma Oncology Center, Santa Monica, California., Roggia C; Department of Neurology & Interdisciplinary Neurooncology, University Hospital of Tübingen, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology at Comprehensive Cancer Center Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany., Genvresse I; Pharmaceuticals Division, Bayer AG, Berlin, Germany., Munhoz C; Bayer HealthCare, São Paulo, Brazil., Rentzsch C; Pharmaceuticals Division, Bayer AG, Berlin, Germany., Reschke S; Pharmaceuticals Division, Bayer AG, Berlin, Germany., Langer S; Early Development Statistics - Oncology, Chrestos Concept GmbH & Co. KG, Essen, Germany., Wagner M; Pharmaceuticals Division, Bayer AG, Berlin, Germany., Kaulfuss S; Pharmaceuticals Division, Bayer AG, Berlin, Germany., Cai C; Pharmaceuticals Division, Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey., Lagkadinou E; Pharmaceuticals Division, Bayer AG, Berlin, Germany., Jeffers M; Pharmaceuticals Division, Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey., Peña C; Pharmaceuticals Division, Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey., Tabatabai G; Department of Neurology & Interdisciplinary Neurooncology, University Hospital of Tübingen, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology at Comprehensive Cancer Center Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 May 15; Vol. 27 (10), pp. 2723-2733. Date of Electronic Publication: 2021 Feb 23.
Autor:
Somaiah N; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Chawla SP; Sarcoma Oncology Center, Santa Monica, CA, United States., Block MS; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States., Morris JC; Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, United States., Do K; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Kim JW; Department of Medical Oncology, Yale School of Medicine, New Haven, CT, United States., Druta M; Medical Oncology, Moffitt Cancer Center, Tampa, FL, United States., Sankhala KK; Hematology/Oncology, Cedars-Sinai Medical Center, Beverly Hills, CA, United States., Hwu P; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Jones RL; Seattle Cancer Care Alliance, Seattle, WA.; Sarcoma Unit, Royal Marsden Hospital, London, UK.; Sarcoma Clinical Trials, Institute of Cancer Research, London, UK., Gnjatic S; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Kim-Schulze S; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Tuballes K; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Yishak M; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Lu H; Immune Design Corp., South San Francisco, CA, United States.; Biomarkers and Diagnostics, Seattle Genetics, Inc, Bothell, WA, United States., Yakovich A; Immune Design Corp., South San Francisco, CA, United States.; Medical Affairs, Replimune Group, Inc, Woburn, MA, United States., Ter Meulen J; Immune Design Corp., South San Francisco, CA, United States., Chen M; Immune Design Corp., South San Francisco, CA, United States.; Sangamo Therapeutics, Inc., Brisbane, CA, United States., Kenney RT; Immune Design Corp., South San Francisco, CA, United States.; Clin Reg Biologics, LLC, Potomac, MD, United States., Bohac C; Immune Design Corp., South San Francisco, CA, United States.; Macrogenics, Inc, Rockville, MD, United States., Pollack SM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2020 Nov 19; Vol. 9 (1), pp. 1847846. Date of Electronic Publication: 2020 Nov 19.
Autor:
Mita MM; Institute for Drug Development, Cancer Therapy and Research Center at University of Texas Health Science Center, San Antonio, TX 78229, USA., Mita AC; Institute for Drug Development, Cancer Therapy and Research Center at University of Texas Health Science Center, San Antonio, TX 78229, USA., Moseley JL; Institute for Drug Development, Cancer Therapy and Research Center at University of Texas Health Science Center, San Antonio, TX 78229, USA., Poon J; Merck & Co., Inc., Kenilworth, NJ 07033, USA., Small KA; Merck & Co., Inc., Kenilworth, NJ 07033, USA., Jou YM; Merck & Co., Inc., Kenilworth, NJ 07033, USA., Kirschmeier P; Merck & Co., Inc., Kenilworth, NJ 07033, USA., Zhang D; Merck & Co., Inc., Kenilworth, NJ 07033, USA., Zhu Y; Merck & Co., Inc., Kenilworth, NJ 07033, USA., Statkevich P; Merck & Co., Inc., Kenilworth, NJ 07033, USA., Sankhala KK; Institute for Drug Development, Cancer Therapy and Research Center at University of Texas Health Science Center, San Antonio, TX 78229, USA., Sarantopoulos J; Institute for Drug Development, Cancer Therapy and Research Center at University of Texas Health Science Center, San Antonio, TX 78229, USA., Cleary JM; Early Drug Development Center, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA., Chirieac LR; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA., Rodig SJ; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA., Bannerji R; Merck & Co., Inc., Kenilworth, NJ 07033, USA., Shapiro GI; Early Drug Development Center, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA.
Publikováno v:
British journal of cancer [Br J Cancer] 2017 Oct 24; Vol. 117 (9), pp. 1258-1268. Date of Electronic Publication: 2017 Aug 31.
Autor:
Palmerini E; Istituto Ortopedico Rizzoli, Bologna, Italy. Electronic address: emanuela.palmerini@ior.it., Chawla NS; Sarcoma Oncology Center, Santa Monica, CA, USA., Ferrari S; Istituto Ortopedico Rizzoli, Bologna, Italy., Sudan M; Sarcoma Oncology Center, Santa Monica, CA, USA., Picci P; Istituto Ortopedico Rizzoli, Bologna, Italy., Marchesi E; Istituto Ortopedico Rizzoli, Bologna, Italy., Leopardi MP; Istituto Ortopedico Rizzoli, Bologna, Italy., Syed I; Sarcoma Oncology Center, Santa Monica, CA, USA., Sankhala KK; Sarcoma Oncology Center, Santa Monica, CA, USA., Parthasarathy P; Sarcoma Oncology Center, Santa Monica, CA, USA., Mendanha WE; Sarcoma Oncology Center, Santa Monica, CA, USA., Pierini M; Istituto Ortopedico Rizzoli, Bologna, Italy., Paioli A; Istituto Ortopedico Rizzoli, Bologna, Italy., Chawla SP; Sarcoma Oncology Center, Santa Monica, CA, USA.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2017 May; Vol. 76, pp. 118-124. Date of Electronic Publication: 2017 Mar 17.
Autor:
Sankhala KK; a Translational and Clinical Research , Sarcoma Oncology Center , Santa Monica , CA , USA.
Publikováno v:
Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2017 Apr; Vol. 26 (4), pp. 427-443. Date of Electronic Publication: 2017 Mar 20.